Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,098 | -6,227 | -2,091 | -1,194 | -258 |
| Depreciation Amortization | 130 | 682 | 537 | 367 | 188 |
| Accounts payable and accrued liabilities | -3,289 | 299 | -2,235 | -2,159 | -2,985 |
| Other Working Capital | -16,693 | -16,081 | -8,020 | -11,748 | 598 |
| Other Operating Activity | 4,892 | 2,068 | 3,686 | 2,894 | 3,274 |
| Operating Cash Flow | $-22,058 | $-19,259 | $-8,123 | $-11,840 | $817 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34 | -340 | -281 | -167 | -16 |
| Net Acquisitions | N/A | 1 | N/A | N/A | N/A |
| Investing Cash Flow | $-34 | $-339 | $-281 | $-167 | $-16 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 265 | N/A | N/A | N/A |
| Debt Repayment | -45 | -45 | -45 | -45 | -45 |
| Common Stock Issued | 241 | 64,709 | 64,632 | 64,731 | N/A |
| Other Financing Activity | -160 | -2,607 | -2,531 | -2,322 | -911 |
| Financing Cash Flow | $20,036 | $62,322 | $62,056 | $62,364 | $-956 |
| Beginning Cash Position | 84,732 | 42,008 | 42,008 | 42,008 | 42,008 |
| End Cash Position | 82,676 | 84,732 | 95,660 | 92,365 | 41,853 |
| Net Cash Flow | $-2,056 | $42,724 | $53,652 | $50,357 | $-155 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,058 | -19,259 | -8,123 | -11,840 | 817 |
| Capital Expenditure | -34 | -340 | -281 | -167 | -16 |
| Free Cash Flow | -22,092 | -19,599 | -8,404 | -12,007 | 801 |